Top Markets
#1 Ontology Gas Ontology Gas +31.11%
#2 Verus Coin Verus Coin +22.50%
#3 Status Status +21.81%
#4 Bitway Bitway +15.86%
#5 ETHGas ETHGas +15.11%
#6 Geodnet Geodnet +14.89%
#7 The Black Bull The Black Bull +11.57%
#8 Derive Derive +11.47%
#9 Curve DAO Curve DAO +11.06%
#10 Fake World Assets Fake World Assets +10.89%
Coin of the day
Ontology Gas Ontology Gas
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Singular Genomics Systems, Inc. Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc.

OMIC
Classifica tra le azioni #25549
Singular Genomics Systems, Inc. is a life science technology firm focused on... Singular Genomics Systems, Inc. is a life science technology firm focused on creating advanced next-generation sequencing and multiomics solutions. The company aims to provide researchers and clinicians with innovative tools to accelerate scientific discovery and medical advancements. Among its core products is the G4 Instrument, a compact next-generation sequencer designed to deliver genetic sequencing results, supported by a selection of complementary consumable kits. Singular Genomics also offers the PX Integrated Solution, a versatile multiomics platform that consolidates single-cell analysis, spatial analysis, genomics, and proteomics into a single, unified instrument. To ensure broad compatibility for the G4, the company maintains strategic partnerships with entities like Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics for the validation of their library preparation kits. Additionally, a collaboration with the Broad Institute of MIT and Harvard enables the G4's integration with the Terra data platform. Established in 2016, Singular Genomics Systems, Inc. is headquartered in La Jolla, California.
Prezzo delle azioni
$20.01
Ultima sincronizzazione: 2025-02-21
Capitalizzazione di mercato
$48.36M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Singular Genomics Systems, Inc. (OMIC)

Categoria

Healthcare
Ricavi di Singular Genomics Systems, Inc. (OMIC)
Ricavi nel Sep 2024 TTM: $2.67M
Secondo gli ultimi rapporti finanziari di Singular Genomics Systems, Inc., i ricavi attuali dell'azienda (TTM) sono pari a $2.67M. Nel 2022, l'azienda ha registrato ricavi di $765.00K un aumento rispetto a i ricavi dell'anno 2021, che erano pari a 0.00. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Singular Genomics Systems, Inc. da 2019 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
2026 (TTM) $2.67M -8.42%
2023 $2.91M 280.52%
2022 $765.00K 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 $11.03B 413,793.47%
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 $34.74B 1,302,846.52%
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 - -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
 $20.84B 781,557.91%
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 - -
CH